![](/img/cover-not-exists.png)
Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back
Avan, Amir, Pacetti, Paola, Reni, Michele, Milella, Michele, Vasile, Enrico, Mambrini, Andrea, Vaccaro, Vanja, Caponi, Sara, Cereda, Stefano, Peters, Godefridus J., Cantore, Maurizio, Giovannetti, EliVolume:
133
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.28078
Date:
August, 2013
File:
PDF, 1.29 MB
english, 2013